K212291 is an FDA 510(k) clearance for the PHOENIX. Classified as System, X-ray, Mobile (product code IZL), Class II - Special Controls.
Submitted by Sedecal., Sa. (Algete, ES). The FDA issued a Cleared decision on September 14, 2021 after a review of 54 days - a notably fast clearance cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1720 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Sedecal., Sa. devices